Fishetti Gary P's Form 4 filing
Anika Therapeutics, Inc. (ANIK) · filed Aug 5, 2026
- Accession no.
- 0001193125-26-335269
- Filed
- Aug 5, 2026, 4:30 PM ET
- Trade date
- Aug 3-4, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $41.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Fishetti Gary PCIK 0001929510 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | Common Stock | PPurchaseAcquired | +1,000 | $20.75 | +$20,745 | 53,015 | Direct | |
| Aug 4, 2026 | Common Stock | PPurchaseAcquired | +1,000 | $20.32 | +$20,315 | 54,015 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.